Current medical guidance recommends against semaglutide during breastfeeding because the medication enters breast milk in animal studies and no human safety data exists
The difference between clinically meaningful fat mobilisation and wasted injection volume comes down to three variables most guides ignore: methyl donor depletion rate, injection site rotation discipline, and the timing relationship between dosing and caloric restriction phases
The MHRA has issued safety alerts warning patients about the risks of purchasing weight loss injections from unregulated sources, including counterfeit products (for example, counterfeit Ozempic pens have been identified in the UK supply chain)
Because myasthenia gravis indicates a broader loss of immune tolerance
2 Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
Glutathione (GSH), a key antioxidant against oxidative damage, is involved in one of the most important metabolic pathways of ferroptosis